CA2068222A1 - Anticorps monoclonaux - Google Patents

Anticorps monoclonaux

Info

Publication number
CA2068222A1
CA2068222A1 CA2068222A CA2068222A CA2068222A1 CA 2068222 A1 CA2068222 A1 CA 2068222A1 CA 2068222 A CA2068222 A CA 2068222A CA 2068222 A CA2068222 A CA 2068222A CA 2068222 A1 CA2068222 A1 CA 2068222A1
Authority
CA
Canada
Prior art keywords
rhesus
antibody molecules
monoclonal antibodies
chimeric antibody
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2068222A
Other languages
English (en)
Other versions
CA2068222C (fr
Inventor
Nevin Campbell Hughes-Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Blood Authority
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2068222A1 publication Critical patent/CA2068222A1/fr
Application granted granted Critical
Publication of CA2068222C publication Critical patent/CA2068222C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention décrit des séquences d'ADN encodant des régions, déterminant la complémentarité, de domaines variables d'anticorps humains anti-RhD, et leur emploi dans la production de molécules d'anticorps chimériques de recombinaison.
CA002068222A 1989-11-13 1990-11-13 Anticorps monoclonaux Expired - Lifetime CA2068222C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8925590.5 1989-11-13
GB898925590A GB8925590D0 (en) 1989-11-13 1989-11-13 Monoclonal antibodies
PCT/EP1990/001964 WO1991007492A1 (fr) 1989-11-13 1990-11-13 Anticorps monoclonaux

Publications (2)

Publication Number Publication Date
CA2068222A1 true CA2068222A1 (fr) 1991-05-14
CA2068222C CA2068222C (fr) 1999-05-11

Family

ID=10666204

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002068222A Expired - Lifetime CA2068222C (fr) 1989-11-13 1990-11-13 Anticorps monoclonaux

Country Status (11)

Country Link
US (2) US5831063A (fr)
EP (1) EP0500659B1 (fr)
AT (1) ATE148168T1 (fr)
AU (1) AU647054B2 (fr)
CA (1) CA2068222C (fr)
DE (1) DE69029808T2 (fr)
DK (1) DK0500659T3 (fr)
ES (1) ES2098274T3 (fr)
GB (1) GB8925590D0 (fr)
GR (1) GR3022847T3 (fr)
WO (1) WO1991007492A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5495002A (en) * 1984-01-31 1996-02-27 Akzo N.V. Tumor associated monoclonal antibody 123AV16
GB9020282D0 (en) 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation
US6326488B1 (en) 1990-10-19 2001-12-04 Board Of Trustees Of University Of Illinois Gene and genetic elements associated with sensitivity to chemotherapeutic drugs
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
WO1994004679A1 (fr) * 1991-06-14 1994-03-03 Genentech, Inc. Procede pour fabriquer des anticorps humanises
WO1992022653A1 (fr) * 1991-06-14 1992-12-23 Genentech, Inc. Procede de production d'anticorps humanises
ES2199216T3 (es) * 1991-07-15 2004-02-16 The Wellcome Foundation Limited Produccion de anticuerpos.
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
ATE272116T1 (de) * 1996-06-24 2004-08-15 Zlb Bioplasma Ag Polypeptide mit der möglichkeit rhesus d antigenspezifische bindungsstrukturen aus zu bilden, dafür kodierende dna und deren prozess der herstellung und anwendung
JP5198704B2 (ja) 2000-03-03 2013-05-15 メディミューン リミティド エオタキシンに対するヒト抗体及びそれらの使用
US6946546B2 (en) 2000-03-06 2005-09-20 Cambridge Antibody Technology Limited Human antibodies against eotaxin
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
DK1395669T3 (da) * 2001-01-26 2009-11-16 Selexis Sa Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
WO2003000908A1 (fr) * 2001-06-21 2003-01-03 Ecole Polytechnique Federale De Lausanne Procede relatif a l'insertion d'un acide nucleique dans une cellule eucaryote
US7658924B2 (en) * 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
GB0324368D0 (en) * 2003-10-17 2003-11-19 Univ Cambridge Tech Polypeptides including modified constant regions
EP2292754B1 (fr) 2003-10-24 2012-12-26 Selexis S.A. Transfert et expression génique à efficacité élevée dans des cellules de mammifères au moyen d'une procédure de transfection multiple de séquences MAR
PT2215119E (pt) * 2007-11-13 2013-02-11 Boehringer Ingelheim Int Anticorpos monoclonais que se ligam a hgm-csf e composições médicas que os compreendem
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB8610106D0 (en) * 1986-04-25 1986-05-29 Central Blood Lab Authority Human igm-producing heterohybridoma
AU623345B2 (en) * 1987-09-18 1992-05-14 National Blood Authority Human anti-rh(d) monoclonal antibodies
AU622417B2 (en) * 1987-09-18 1992-04-09 National Blood Authority Human anti-rh(d) monoclonal antibodies

Also Published As

Publication number Publication date
WO1991007492A1 (fr) 1991-05-30
AU647054B2 (en) 1994-03-17
US5831063A (en) 1998-11-03
DE69029808T2 (de) 1997-07-10
ATE148168T1 (de) 1997-02-15
US5919910A (en) 1999-07-06
DE69029808D1 (de) 1997-03-06
GR3022847T3 (en) 1997-06-30
AU6721490A (en) 1991-06-13
GB8925590D0 (en) 1990-01-04
CA2068222C (fr) 1999-05-11
EP0500659A1 (fr) 1992-09-02
ES2098274T3 (es) 1997-05-01
EP0500659B1 (fr) 1997-01-22
DK0500659T3 (da) 1997-07-14

Similar Documents

Publication Publication Date Title
CA2068222A1 (fr) Anticorps monoclonaux
WO2002020569A3 (fr) Genes mammaliens, reactifs et methodes associes
WO1998050433A3 (fr) Anticorps monoclonaux humains contre le recepteur du facteur de croissance epidermique
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
MY145191A (en) Human antibodies that bind human il-12 and methods for producing
BR9507594B8 (pt) Anticorpo monoclonal com scfv humanizado, molécula de ácido nucleico recombinante e proteína recombinante.
UA83791C2 (ru) Антитело против vla-1, фармацевтическая композиция, которая его содержит, и из применение для лечения индивидуума с иммунологическим расстройством, опосредованным vla-1
WO2001090358A3 (fr) Proteines de recepteurs de mammiferes, reactifs et procedes apparentes
WO2001085790A3 (fr) Proteines de recepteur de mammifere, reactifs lies et techniques
GB8806339D0 (en) Monoclonal antibodies
IL162117A0 (en) Humanized collagen antibodies and methods utilizing the same
EP1433792A3 (fr) Protéines réceptrices humaines, réactifs et méthodes associés
NZ333329A (en) Polypeptides capable of forming antigen binding structures with specificity for rhesus d antigens
IL116617A0 (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
WO2001036467A3 (fr) Proteines de recepteurs mammaliens, reactifs et procedes s'y rapportant
DE69535562D1 (de) Rekombinantpeptide hergeleitet vom mc3 antikörper gegen ba46, verfahren zu deren verwendung und verfahren zur humanisierung von antikörperpeptiden
WO2002074251A3 (fr) Traitement par anticorps monoclonal du cancer du pancreas
WO1999046379A3 (fr) Proteines receptrices humaines; reactifs et procedes associes
WO2001057219A3 (fr) Cytokines mammaliennes, leurs recepteurs, reactifs et procedes correspondants
EP0972054A4 (fr) Amelioration de la reaction immune au moyen de molecules de ciblage
NO179328C (no) Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom
EP0723663A4 (fr) Hybridome et anticorps monoclonal humanise anti kc-4, adn et arn codant ce dernier, trousse, et procedes diagnostiques et therapeutiques
WO2001002429A3 (fr) Angiopoietine 6 et ses utilisations
WO2000017363A3 (fr) MOLECULE DU TYPE INTERLEUKINE-1: INTERLEUKINE-1z, ACIDES NUCLEIQUES, POLYPEPTIDES, ANTICORPS ET LEURS APPLICATIONS

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202